Trials / Conditions / Osteosarcoma Metastatic

Osteosarcoma Metastatic

7 registered clinical trials studyying Osteosarcoma Metastatic — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma NCT07479732	Peking University People's Hospital	Phase 1 / Phase 2
Not Yet Recruiting	A Look Back at How Well Interventional Treatments Work for Bronchopleural Fistulas in Patients With Lung Metas NCT06927596	Ruijin Hospital	—
Active Not Recruiting	SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma NCT04803877	Sarcoma Alliance for Research through Collaboration	Phase 2
Completed	Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma NCT04651179	Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna	—
Completed	Osteosarcoma With Resectable Pulmonary Metastasis: A Retrospective Study NCT04546243	Peking University People's Hospital	—
Withdrawn	BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung Metastases NCT04183062	Nicklaus Children's Hospital f/k/a Miami Children's Hospital	Phase 2
Completed	Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma Metastatic to the Lung NCT00102531	Insmed Incorporated	Phase 1 / Phase 2